Evaluation of fully oxidised β-carotene as a feed ingredient to reduce bacterial infection and somatic cell counts in pasture-fed cows with subclinical mastitis
dc.citation.issue | 5 | |
dc.citation.volume | 69 | |
dc.contributor.author | McDougall S | |
dc.coverage.spatial | England | |
dc.date.accessioned | 2024-02-02T02:22:29Z | |
dc.date.accessioned | 2024-07-25T06:32:03Z | |
dc.date.available | 2021-06-09 | |
dc.date.available | 2024-02-02T02:22:29Z | |
dc.date.available | 2024-07-25T06:32:03Z | |
dc.date.issued | 2021-09 | |
dc.description.abstract | AIMS: To assess the effect of oral supplementation with fully oxidised β-carotene (OxBC) on bacteriological cure, the incidence of clinical mastitis, and somatic cell counts (SCC) in pasture-fed cows with subclinical intramammary infection. METHODS: Cows from four dairy herds were enrolled in early lactation if they had quarter-level SCC >200,000 cells/mL and they had a recognised bacterial intramammary pathogen in one or more quarters. They were randomly assigned to be individually fed from Day 0, for a mean of 40 days, with 0.5 kg of a cereal-based supplementary feed that either contained 300 mg of OxBC (treatment; n = 129 quarters) or did not (control; n = 135 quarters). Quarter-milk samples were collected on Days 21 and 42 for microbiology and SCC assessment. Bacteriological cure was defined as having occurred when the bacteria present on Day 0 were not isolated from samples collected on Days 21 or 42. A new intramammary infection was defined as a bacterial species isolated either on Day 21 or 42 differing from that isolated on Day 0. Clinical mastitis was diagnosed and recorded by herdowners up to Day 42. RESULTS: The bacteriological cure rate was greater for quarters from cows in the treatment group (13.9 (95% CI = 4.1-23.7)%) than for cows in the control group (6.9 (95% CI = 4.8-9.1)%; p = 0.02). The percentage of quarters that developed a new intramammary infection at Day 21 or 42 was greater for cows in the treatment group (17.9 (95% CI = 6.7-29.1)%) than for cows in the control group (13.0 (95% CI = 4.3-21.8)%; p < 0.01). The prevalence of quarters that were infected on Day 42 was less in cows in the treatment group (79.9 (95% CI = 62.3-97.6)%) than the control group (88.2 (95% CI = 78.4-97.9)%; p = 0.009). The incidence of quarters diagnosed with clinical mastitis by Day 42 was lower in cows from the treatment group (1/129 (0.78 (95% CI = 0.02-4.24)%)) than in cows from the control group (6/135 (4.44 (95% CI = 1.65-9.42)%; p = 0.03)). Mean quarter-level SCC was not statistically different between treatment groups (p = 0.34). CONCLUSIONS AND CLINICAL RELEVANCE: Feeding 300 mg/cow/day of OxBC resulted in a higher bacteriological cure rate, a lower prevalence of intramammary infection, and a lower incidence of clinical mastitis compared to untreated controls. However new intramammary infections increased in treated cows, and the magnitude of the increased bacteriological cure was low, resulting in 80% of cows remaining infected at Day 42. Therefore treatment with OxBC should be considered as an adjunct to other mastitis control measures. | |
dc.description.confidential | false | |
dc.format.pagination | 285-293 | |
dc.identifier.author-url | https://www.ncbi.nlm.nih.gov/pubmed/33944703 | |
dc.identifier.citation | McDougall S. (2021). Evaluation of fully oxidised β-carotene as a feed ingredient to reduce bacterial infection and somatic cell counts in pasture-fed cows with subclinical mastitis.. N Z Vet J. 69. 5. (pp. 285-293). | |
dc.identifier.doi | 10.1080/00480169.2021.1924091 | |
dc.identifier.eissn | 1176-0710 | |
dc.identifier.elements-type | journal-article | |
dc.identifier.issn | 0048-0169 | |
dc.identifier.uri | https://mro.massey.ac.nz/handle/10179/70367 | |
dc.language | eng | |
dc.publisher | Taylor and Francis Group on behalf of the New Zealand Veterinary Association | |
dc.publisher.uri | https://www.tandfonline.com/doi/full/10.1080/00480169.2021.1924091 | |
dc.relation.isPartOf | N Z Vet J | |
dc.rights | (c) The author/s | en |
dc.rights.license | CC BY-NC-ND 4.0 | en |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | en |
dc.subject | Oxidised β-carotene | |
dc.subject | cure | |
dc.subject | dairy cow | |
dc.subject | intramammary infection | |
dc.subject | prevalence | |
dc.subject | Animals | |
dc.subject | Anti-Bacterial Agents | |
dc.subject | Bacterial Infections | |
dc.subject | Cattle | |
dc.subject | Cattle Diseases | |
dc.subject | Cell Count | |
dc.subject | Female | |
dc.subject | Lactation | |
dc.subject | Mammary Glands, Animal | |
dc.subject | Mastitis | |
dc.subject | Mastitis, Bovine | |
dc.subject | Milk | |
dc.subject | beta Carotene | |
dc.title | Evaluation of fully oxidised β-carotene as a feed ingredient to reduce bacterial infection and somatic cell counts in pasture-fed cows with subclinical mastitis | |
dc.type | Journal article | |
pubs.elements-id | 446794 | |
pubs.organisational-group | Other |